Swollen Legs

Risk Factors for Swollen Legs

  • Prolonged sitting
  • Prolonged standing
  • Surgery (Neurosurgery, orthopaedic, Gynaecological and gastrointestinal surgeries)
  • Hospitalization
  • Obesity
  • Smoking
  • Pregnancy
  • Diabetes
  • Injury to the leg (with or without surgery/casting)
  • Airplane flights (>4hrs)
  • Medications (estrogen)

Traditional Treatments for Swollen Legs

  • Graduated compression stockings
  • Anti-coagulants
  • Pneumatic compression device

How the Venowave Can Help

The Venowave has been scientifically proven to alleviate the symptoms of a wide variety of circulation-related conditions. It sits on the back of the calf and mimics the body’s vein system by forcing the blood from the affected leg. The pumping action reduces swelling, pain, and heaviness. The Venowave is a unique, lightweight (350 grams or 12 ounces) and discreet medical device that allows patients to remain completely mobile. There are no wires, tubes or sleeves and the device can be worn all day long.

The Venowave is Useful For:

  • Compression
  • Post-thrombotic syndrome prevention
  • Management of the symptoms of post-thrombotic syndrome (PTS)
  • Treatment of leg swelling due to vascular insufficiency
  • Treatment of varicose veins
  • Treatment of chronic venous insufficiency (CVI)

The Efficacy of Venowave is Clinically Proven

The Venowave works because it pumps blood upwards towards the heart. Indeed, the Venowave increases blood flow in major veins in the leg increases as much as 88%. (Source: Blood, Journal of the American Society of Hematology, 2002)

Leading Doctors Recommend the Venowave

“In individuals who have chronic leg swelling, the Venowave can be very helpful.”
Dr. Sonia Anand, Director of Vascular Medicine, McMaster University, Canada

“Venowave appears to be a very promising new therapy.”
Dr. Martin J. O’Donnell et al., who conducted a randomized, placebo-controlled, double-blinded “cross-over” trial of the Venowave, the protocol of which was approved by Health Canada (No. 64844). The trial was also conducted according to the ICH-Good Clinical Practice guidelines.